Randal J. Kirk
Description
R.J. Kirk is Chairman and Chief Executive Officer of Intrexon, a leading synthetic biology technology company. Mr. Kirk was named Chairman ...
Investor Profile
Randal J. Kirk has backed more than 3 startups, with 1 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 2 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series F, Series E, Post Ipo Equity rounds (top funding stages).
- Majority of deals are located in United States.
- Strong thematic focus on Biotechnology, Life Science, Medical.
Stage Focus
- Series F (33%)
- Series E (33%)
- Post Ipo Equity (33%)
Country Focus
- United States (100%)
Industry Focus
- Biotechnology
- Life Science
- Medical
- Therapeutics
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
